These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8316049)

  • 1. Compounds biologically similar to platelet activating factor are present in stored blood components.
    Silliman CC; Johnson CA; Clay KL; Thurman GW; Ambruso DR
    Lipids; 1993 May; 28(5):415-8. PubMed ID: 8316049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase.
    Silliman CC; Clay KL; Thurman GW; Johnson CA; Ambruso DR
    J Lab Clin Med; 1994 Nov; 124(5):684-94. PubMed ID: 7964126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates.
    Silliman CC; Dickey WO; Paterson AJ; Thurman GW; Clay KL; Johnson CA; Ambruso DR
    Transfusion; 1996 Feb; 36(2):133-9. PubMed ID: 8614963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor.
    Silliman CC; Thurman GW; Ambruso DR
    Vox Sang; 1992; 63(2):133-6. PubMed ID: 1332255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
    Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WEB2170, a specific platelet-activating factor antagonist, attenuates neutrophil priming by human serum after clinical burn injury: the 1991 Moyer Award.
    Pitman JM; Thurman GW; Anderson BO; Ketch LL; Hartford CE; Harken AH; Ambruso DR
    J Burn Care Rehabil; 1991; 12(5):411-9. PubMed ID: 1661287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: comparison with bioassay and GC/MS techniques.
    Sugatani J; Lee DY; Hughes KT; Saito K
    Life Sci; 1990; 46(20):1443-50. PubMed ID: 2111868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
    Subbanagounder G; Leitinger N; Shih PT; Faull KF; Berliner JA
    Circ Res; 1999 Aug; 85(4):311-8. PubMed ID: 10455059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a platelet-activating factor antagonist on pancreas perfusion after 24 h of ischemia.
    Leonhardt U; Exner B; Schrock E; Ritzel U; Nebendahl K; Stöckmann F
    Pancreas; 1995 Aug; 11(2):160-4. PubMed ID: 7479673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: present status.
    Casals-Stenzel J
    Lipids; 1991 Dec; 26(12):1157-61. PubMed ID: 1668111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
    Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
    Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.
    Mueller HW; Haught CA; McNatt JM; Cui K; Gaskell SJ; Johnston DA; Willerson JT
    Circ Res; 1995 Jul; 77(1):54-63. PubMed ID: 7788882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of inhibitors of platelet aggregation on the metabolism of platelet-activating factor (PAF) in washed rabbit platelets.
    O'Neill C; Ammit AJ; Korth R; Fleming S; Wells X
    Lipids; 1991 Dec; 26(12):1011-4. PubMed ID: 1726442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function.
    Dent G; Ukena D; Chanez P; Sybrecht G; Barnes P
    FEBS Lett; 1989 Feb; 244(2):365-8. PubMed ID: 2537761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.